|
CDH
|
Positive Acute Phase Response Proteins
|
5.1E-05
|
6/30 (0.2)
|
MDH
|
Negative Acute Phase Response Proteins
|
2.07E-05
|
5/8 (0.625)
|
|
CDH
|
Aryl Hydrocarbon Receptor Signaling
|
2.66E-04
|
12/157 (0.076)
|
MDH
|
p53 Signaling
|
4.86E-04
|
14/95 (0.147)
|
|
CDH
|
Cell Cycle: G1/S Checkpoint Regulation
|
3.04E-04
|
7/57 (0.123)
|
MDH
|
Liver Proliferation
|
7.01E-04
|
17/133 (0.128)
|
|
CDH
|
Negative Acute Phase Response Proteins
|
6.08E-04
|
3/8 (0.375)
|
MDH
|
Oxidative Stress
|
7.68E-04
|
10/57 (0.175)
|
|
CDH
|
Fatty Acid Metabolism
|
2.06E-03
|
9/123 (0.073)
|
MDH
|
Cholesterol Biosynthesis
|
1.13E-03
|
5/16 (0.312)
|
|
CDM
|
FXR/RXR Activation
|
3.6E-07
|
6/87 (0.069)
|
MDM
|
Aryl Hydrocarbon Receptor Signaling 4
|
6.02E-04
|
5/157 (0.032)
|
|
CDM
|
LXR/RXR Activation
|
2.28E-06
|
6/119 (0.05)
|
MDM
|
Xenobiotic Metabolism Signaling
|
7.95E-04
|
7/349 (0.02)
|
|
CDM
|
Positive Acute Phase Response Proteins
|
2.52E-06
|
4/30 (0.133)
|
MDM
|
Cytochrome P450 Panel - Substrate is a Xenobiotic (Human)
|
2.71E-03
|
2/18 (0.111)
|
|
CDM
|
Fatty Acid Metabolism
|
6.67E-04
|
4/123 (0.033)
|
MDM
|
NRF2-mediated Oxidative Stress Response
|
3.69E-03
|
5/237 (0.021)
|
|
CDM
|
Xenobiotic Metabolism Signaling
|
8.92E-04
|
6/349 (0.017)
| | | | |
| | | | |
MDL
|
Negative Acute Phase Response Proteins
|
3.6E-05
|
2/8 (0.25)
|
| | | | |
MDL
|
Decreases Respiration of Mitochondria
|
7.05E-05
|
2/11 (0.182)
|
| | | | |
MDL
|
LXR/RXR Activation
|
3.42E-04
|
3/119 (0.025)
|
| | | | |
MDL
|
TR/RXR Activation
|
4.45E-03
|
2/86 (0.023)
|
